65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03597594 (ClinicalTrials.gov)	September 8, 2021	19/6/2018	Haplocompatible Transplant Using TCRa/ß Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infus ...	Haplocompatible Transplant Using TCRa/ß Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infus ...	Severe Combined Immunodeficiency	Drug: Anti-thymocyte globulin (rabbit);Drug: Busulfan;Drug: Fludarabine;Drug: Thiotepa;Device: Clini ...	St. Jude Children's Research Hospital	NULL	Recruiting	2 Months	N/A	All	42	Phase 1/Phase 2	United States
2	NCT03513328 (ClinicalTrials.gov)	June 15, 2018	19/4/2018	Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation	PEDS024, Phase I/II Feasibility Study of Busulfan Fludarabine and ThiotepaConditioning Regimen for A ...	Bone Marrow Failure Syndrome;Thalassemia;Sickle Cell Disease;Diamond Blackfan Anemia;Acquired Neutro ...	Drug: Thiotepa --single daily dose;Drug: Thiotepa --escalated dose	University of Florida	Live Like Bella Pediatric Cancer Research	Active, not recruiting	3 Months	39 Years	All	6	Phase 1/Phase 2	United States
3	NCT01962415 (ClinicalTrials.gov)	February 4, 2014	10/10/2013	Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT	A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults =55 Years ...	Primary Immunodeficiency (PID);Congenital Bone Marrow Failure Syndromes;Inherited Metabolic Disorder ...	Drug: Hydroxyurea;Drug: Alemtuzumab;Drug: Fludarabine;Drug: Melphalan;Drug: Thiotepa	Paul Szabolcs	NULL	Recruiting	2 Months	55 Years	All	100	Phase 2	United States
4	NCT01821781 (ClinicalTrials.gov)	March 2013	19/3/2013	Immune Disorder HSCT Protocol	A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduc ...	Immune Deficiency Disorders;Severe Combined Immunodeficiency;Chronic Granulomatous Disease;X-linked ...	Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan	Washington University School of Medicine	NULL	Recruiting	N/A	21 Years	All	20	Phase 2	United States
5	NCT00160355 (ClinicalTrials.gov)	May 2005	8/9/2005	Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome	Haploidentical Hematopoietic Stem Cell Transplantation for Pediatric Patients With Wiskott-Aldrich S ...	Wiskott-Aldrich Syndrome	Procedure: Hematopoietic stem cell transplantation;Device: Miltenyi CliniMACS selection system;Drug: ...	St. Jude Children's Research Hospital	NULL	Completed	N/A	18 Years	Male	4	Phase 1	United States
6	NCT00295971 (ClinicalTrials.gov)	April 2005	23/2/2006	Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone ...	Stem Cell Enriched, T Cell Depleted Haplocompatible Peripheral Blood Transplantation for Children Wi ...	Congenital Amegakaryocytic Thrombocytopenia;Leukemia;Myelodysplastic Syndromes;Severe Congenital Neu ...	Biological: anti-thymocyte globulin;Biological: therapeutic allogeneic lymphocytes;Drug: fludarabine ...	University of California, San Francisco	National Cancer Institute (NCI)	Completed	1 Year	17 Years	Both	21	Phase 1	United States

First Previous1Next Last